See up to 3 months of UFPT. The 7-day demo opens the 1M and 3M ranges and puts UFPT on your watchlist.
Start 7-day demoLatest UFPT insider trades
About UFP TECHNOLOGIES INC (UFPT)
UFP TECHNOLOGIES INC files with the SEC under CIK 0000914156 and is classified as surgical and medical instruments and apparatus. It is grouped with Health Care companies on this site.
UFPT Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 13 | 40,030 | $12.63M |
| Option exercise | 4 | 2,392 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
UFPT insider transactions (Form 4)
4848 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 1 of 2.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Marc D. Kozin - Director | Open-market sale | Common Stock, $.01 Par Value | 3,650 | $303.97 footnote F1 | $1.11M | |
| Marc D. Kozin - Director | Open-market sale | Common Stock, $.01 Par Value | 3,350 | $305.07 footnote F2 | $1.02M | |
| ||||||
| Symeria Hudson - Director | Open-market sale | Common Stock, $.01 Par Value | 298 | $319.11 | $95K | |
| Symeria Hudson - Director | Option exercise | Common Stock, $.01 Par Value | 703 | $167.98 | $118K | |
| Symeria Hudson - Director | Option exercise | Common Stock, $.01 Par Value | 493 | $260.92 | $129K | |
| Symeria Hudson - Director | Open-market sale | Common Stock, $.01 Par Value | 1,926 | $324.58 footnote F1 | $625K | |
| Symeria Hudson - Director | Option exercise | Stock Option (Right to Buy) | 703 | $0.00 | - | |
| Symeria Hudson - Director | Option exercise | Stock Option (Right to Buy) | 493 | $0.00 | - | |
| ||||||
| Cynthia L. Feldmann - Director | Open-market sale | Common Stock, $.01 Par Value | 1,000 | $324.26 | $324K | |
| R. Jeffrey Bailly - Officer | Open-market sale | Common Stock, $.01 Par Value | 5,771 | $315.53 footnote F1 | $1.82M | |
| R. Jeffrey Bailly - Officer | Open-market sale | Common Stock, $.01 Par Value | 6,866 | $316.58 footnote F2 | $2.17M | |
| R. Jeffrey Bailly - Officer | Open-market sale | Common Stock, $.01 Par Value | 374 | $317.27 footnote F3 | $119K | |
| ||||||
| R. Jeffrey Bailly - Officer | Open-market sale | Common Stock, $.01 Par Value | 7,877 | $318.12 footnote F1 | $2.51M | |
| R. Jeffrey Bailly - Officer | Open-market sale | Common Stock, $.01 Par Value | 2,805 | $320.05 footnote F2 | $898K | |
| R. Jeffrey Bailly - Officer | Open-market sale | Common Stock, $.01 Par Value | 542 | $315.06 | $171K | |
| R. Jeffrey Bailly - Officer | Open-market sale | Common Stock, $.01 Par Value | 4,471 | $318.21 | $1.42M | |
| ||||||
| Jason Holt - Officer | Open-market sale | Common Stock, $.01 Par Value | 1,100 | $317.00 | $349K | |
| Cynthia L. Feldmann - Director | Option exercise | Common Stock, $.01 Par Value | 1,200 | $43.95 | $53K | |
| Cynthia L. Feldmann - Director | Open-market sale | Common Stock, $.01 Par Value | 1,100 | $239.19 | $263K | |
| Cynthia L. Feldmann - Director | Open-market sale | Common Stock, $.01 Par Value | 100 | $240.40 | $24K | |
| Cynthia L. Feldmann - Director | Option exercise | Stock Option (Right to Buy) | 1,200 | $0.00 | - | |
| R. Jeffrey Bailly - Officer | Grant or award | Common Stock, $.01 Par Value | 1,787 | $0.00 | - | |
| R. Jeffrey Bailly - Officer | Tax withholding / forfeiture | Common Stock, $.01 Par Value | 750 | $223.87 | $168K | |
 Ryan K. Stafford - Officer | Grant or award | Common Stock, $.01 Par Value | 1,448 footnote F1 | $0.00 | - | |
| ||||||
| Ronald J. Lataille - Officer | Grant or award | Common Stock, $.01 Par Value | 4,454 footnote F1 | $0.00 | - | |
| ||||||
| Mitchell Rock - Officer | Grant or award | Common Stock, $.01 Par Value | 2,895 footnote F1 | $0.00 | - | |
| ||||||
| Joseph John Hassett - Director | Grant or award | Common Stock, $.01 Par Value | 802 footnote F1 | $0.00 | - | |
| ||||||
| Symeria Hudson - Director | Grant or award | Common Stock, $.01 Par Value | 802 footnote F1 | $0.00 | - | |
| ||||||
| Cynthia L. Feldmann - Director | Grant or award | Common Stock, $.01 Par Value | 802 footnote F1 | $0.00 | - | |
| ||||||
 Daniel C. Croteau - Director | Grant or award | Common Stock, $.01 Par Value | 802 footnote F1 | $0.00 | - | |
| ||||||
| Thomas Oberdorf - Director | Grant or award | Common Stock, $.01 Par Value | 802 footnote F1 | $0.00 | - | |
| ||||||
| Marc D. Kozin - Director | Grant or award | Common Stock, $.01 Par Value | 802 footnote F1 | $0.00 | - | |
| ||||||
| Daniel C. Croteau - Director | Open-market sale | Common Stock, $.01 Par Value | 2,864 | $221.71 | $635K | |
| Daniel C. Croteau - Director | Option exercise | Common Stock, $.01 Par Value | 2,864 | $22.02 | $63K | |
| Daniel C. Croteau - Director | Option exercise | Stock Option (Right to Buy) | 2,864 | $0.00 | - | |
| Thomas Oberdorf - Director | Option exercise | Common Stock, $.01 Par Value | 2,864 | $22.02 | $63K | |
| Thomas Oberdorf - Director | Option exercise | Stock Option (Right to Buy) | 2,864 | $0.00 | - | |
| Jason Holt - Officer | Tax withholding / forfeiture | Common Stock, $.01 Par Value | 478 footnote F1 | $204.30 | $98K | |
| ||||||
| Christopher P. Litterio - Officer | Tax withholding / forfeiture | Common Stock, $.01 Par Value | 815 footnote F1 | $204.30 | $167K | |
| ||||||
| Mitchell Rock - Officer | Tax withholding / forfeiture | Common Stock, $.01 Par Value | 2,513 footnote F1 | $204.30 | $513K | |
| ||||||
| Ronald J. Lataille - Officer | Tax withholding / forfeiture | Common Stock, $.01 Par Value | 2,677 footnote F1 | $204.30 | $547K | |
| ||||||
| R. Jeffrey Bailly - Officer | Tax withholding / forfeiture | Common Stock, $.01 Par Value | 9,422 footnote F1 | $204.30 | $1.92M | |
| ||||||
| Jason Holt - Officer | Grant or award | Common Stock, $.01 Par Value | 657 footnote F1 | $0.00 | - | |
| Jason Holt - Officer | Grant or award | Common Stock, $.01 Par Value | 1,121 footnote F2 | $0.00 | - | |
| ||||||
| Christopher P. Litterio - Officer | Grant or award | Common Stock, $.01 Par Value | 821 footnote F1 | $0.00 | - | |
| Christopher P. Litterio - Officer | Grant or award | Common Stock, $.01 Par Value | 1,215 footnote F2 | $0.00 | - | |
| ||||||
| Mitchell Rock - Officer | Grant or award | Common Stock, $.01 Par Value | 2,463 footnote F1 | $0.00 | - | |
| Mitchell Rock - Officer | Grant or award | Common Stock, $.01 Par Value | 3,270 footnote F2 | $0.00 | - | |
| ||||||
Item 7.01, 9.01
Item 2.02, 9.01
Item 5.02, 7.01, 9.01
Item 7.01, 9.01
Recent UFPT Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Marc D. Kozin | Director | 7,000 | $2.14M | View on EDGAR | |
| Symeria Hudson | Member of Board of Directors | 2,224 |
UFPT insider trading FAQ
What is the latest insider trade for UFPT?
UFP TECHNOLOGIES INC (UFPT) had 8 insider filings in the last 90 days, with the most recent on 27 August 2026. The full record for UFPT runs to 48 Form 4 filings, the earliest from 3 October 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying UFPT stock?
No insider purchases of UFPT were filed in the last 90 days.
How many insiders are selling UFPT stock?
13 insider sales of UFPT were filed in the last 90 days, totaling $12.63M.
Where can I see UFPT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects UFPT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Marc D. Kozin view on EDGAR
- - Symeria Hudson view on EDGAR
- - Symeria Hudson view on EDGAR
- - Cynthia L. Feldmann view on EDGAR
- - Joseph John Hassett view on EDGAR
- - R. Jeffrey Bailly view on EDGAR
- - R. Jeffrey Bailly view on EDGAR
- - Jason Holt view on EDGAR
- - Cynthia L. Feldmann view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where UFPT's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow UFPT with a 7-day demo
- UFPT on your watchlist
- Every UFPT Form 4 filing on record
- Up to 3 months of UFPT price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
